The primary objectives of this study are to examine the safety and potential improvement in immune responses elicited by combining MN rsgp120/HIV-1 with QS21. The secondary objective are to examine the role of alum in the vaccine/adjuvant formulation, to determine the optimal dose ratio of vaccine to adjuvant, and to obtain initial information on the optimal schedule of administration.
Showing the most recent 10 out of 515 publications